Answers are grounded in this paper and cite their sources.
HD-IV reduced the incidence of P&I and all-cause hospitalization vs SD-IV in adults ≥ 65 years in randomized trials, through no significant difference was observed in all-cause death rates. These findings, supported by evidence from several randomized studies, can benefit from replication in a fully powered, individually randomized trial.
No takes yet. Share an insight, caveat, or question.
Skaarup et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: